SOBER1 Antibody

What is SOBER1 and why would researchers need antibodies against it?

SOBER1 is a conserved alpha/beta hydrolase that functions as a suppressor of effector-triggered immunity (ETI) in plants. It was initially identified as a suppressor of Xanthomonas acetyltransferase effector AvrBsT-triggered immunity, but further research has shown it suppresses immunity triggered by multiple bacterial acetyltransferases, including Pseudomonas effector HopZ5 .

Antibodies against SOBER1 are essential research tools for:

• Detecting SOBER1 protein expression in different plant tissues and under various pathogen challenge conditions

• Studying subcellular localization of SOBER1 during immune responses

• Performing immunoprecipitation to identify SOBER1-interacting proteins

• Validating genetic studies with protein-level confirmation

• Investigating how SOBER1 levels correlate with phosphatidic acid accumulation during immune responses

When selecting antibodies for SOBER1 research, consider epitopes that won't interfere with the protein's catalytic activity if functional studies are planned.

What types of experiments can be performed using SOBER1 antibodies?

SOBER1 antibodies enable various experimental approaches for studying plant immunity:

• Western blotting: To detect and quantify SOBER1 protein levels in plant tissues, particularly useful for comparing expression between resistant and susceptible plant varieties.

• Immunoprecipitation (IP): To isolate SOBER1 complexes and identify interacting partners such as bacterial effectors (AvrBsT, HopZ5) or plant immunity components .

• Immunolocalization: To visualize the subcellular distribution of SOBER1 during normal conditions versus pathogen challenge.

• Chromatin immunoprecipitation (ChIP): If SOBER1 has any nuclear roles or associations with transcriptional machinery during immune responses.

• Proximity ligation assay (PLA): To detect and visualize protein-protein interactions involving SOBER1 in situ with nanometer resolution.

Critical controls include tissues from sober1 knockout plants (e.g., the sober1-1 mutant from Arabidopsis Pi-0 ecotype) and competition assays with the immunizing peptide to validate specificity .

How can researchers distinguish between SOBER1 and its homologs when using antibodies?

Distinguishing SOBER1 from related alpha/beta hydrolases requires methodological precision:

• Epitope selection strategy:

  • Target unique regions in SOBER1, particularly its hydrophobic anchor mechanism which defines this deacetylase family

  • Avoid antibodies against the conserved catalytic domain shared by multiple hydrolases

  • Consider antibodies against SOBER1's distinctive lid-loop structure that influences substrate specificity

• Validation methodology:

  • Use tissue from sober1 knockout plants as negative controls

  • Perform parallel detection with multiple antibodies targeting different SOBER1 epitopes

  • Include western blots of recombinant SOBER1 alongside related hydrolases to confirm specificity

• Enhanced specificity approaches:

  • Pre-adsorb antibodies with extracts from plants expressing SOBER1 homologs but lacking SOBER1 itself

  • Combine immunodetection with activity-based protein profiling using probes specific for SOBER1's PLA2 activity

  • Implement two-dimensional electrophoresis to separate hydrolases by both pI and molecular weight before immunodetection

The search results indicate that SOBER1 has a unique hydrophobic anchor that distinguishes it from other deacetylase family members, which can be exploited for generating specific antibodies .

How can researchers optimize immunoprecipitation protocols for SOBER1?

Optimizing SOBER1 immunoprecipitation requires consideration of its phospholipase activity and membrane associations:

Extraction Protocol:

• Buffer optimization:

  • Use a phospholipase-preserving extraction buffer: 50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1% Triton X-100

  • Include protease inhibitor cocktail to prevent degradation

  • Add phosphatase inhibitors if studying phosphorylated forms of SOBER1

• Tissue preparation:

  • Flash-freeze tissue in liquid nitrogen and grind to fine powder

  • Maintain low temperature throughout extraction to preserve enzymatic activity

  • Use a tissue:buffer ratio of 1:3 (w/v) for optimal extraction

Immunoprecipitation Procedure:

• Pre-clearing step:

  • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding

  • Filter through 0.45 μm filter to remove aggregates

• Antibody binding:

  • Use 2-5 μg antibody per 500 μg total protein

  • Incubate with gentle rotation overnight at 4°C

  • For recalcitrant samples, consider crosslinking antibodies to beads

• Washing optimization:

  • Perform 4-5 washes with decreasing detergent concentration

  • Include one stringent wash with higher salt (300 mM NaCl) if background is high

  • Perform final wash in detergent-free buffer if downstream enzymatic assays are planned

This approach has been successful for isolating SOBER1 and its interaction partners, as demonstrated in studies examining its interaction with bacterial effectors .

What controls are essential when using SOBER1 antibodies to study its role in suppressing plant immunity?

When studying SOBER1's suppression of plant immunity, these controls are methodologically essential:

Genetic Controls:

• Knockout/knockdown validation:

  • Include sober1 knockout lines (e.g., sober1-1 from Pi-0 ecotype) as negative controls

  • Use CRISPR/Cas9-generated knockout lines if working beyond Arabidopsis

  • Include heterozygous plants to validate antibody sensitivity to protein levels

• Complementation lines:

  • Test antibodies on knockout plants complemented with:

    • Wild-type SOBER1

    • Catalytically inactive SOBER1 (mutations in the catalytic triad)

    • SOBER1 with altered hydrophobic anchor region

Experimental Treatment Controls:

• Pathogen challenge controls:

  • Compare SOBER1 detection in plants infected with:

    • Bacteria expressing acetyltransferase effectors (AvrBsT, HopZ5)

    • Bacteria with mutated effectors lacking acetyltransferase activity

    • Mock-inoculated plants

• Chemical treatment controls:

  • Include samples treated with phospholipase inhibitors to correlate with SOBER1's enzymatic function

  • Use phospholipase D inhibitors since PLD activity is required for the hypersensitive response that SOBER1 suppresses

• Functional readouts:

  • Correlate antibody detection with phosphatidic acid (PA) measurements, as SOBER1 suppresses PA accumulation

  • Monitor cell death responses in the same tissues used for antibody detection

  • Quantify defense gene expression in parallel samples

This control strategy ensures reliable interpretation of SOBER1's role in suppressing plant immunity by distinguishing specific signals from artifacts.

How can researchers use SOBER1 antibodies to investigate its interaction with bacterial effectors?

Investigating SOBER1's interaction with bacterial effectors requires specialized immunological approaches:

• Co-immunoprecipitation optimization:

  • Use antibodies targeting epitopes away from the effector-binding domains

  • Implement gentler extraction conditions to preserve protein-protein interactions

  • Consider crosslinking approaches to stabilize transient interactions

  • Perform reciprocal co-IPs using both SOBER1 antibodies and tagged effectors (AvrBsT, HopZ5)

• In situ interaction analysis:

  • Develop proximity ligation assay (PLA) protocols specific for SOBER1-effector pairs

  • Use fluorescently-tagged effectors combined with immunodetection of endogenous SOBER1

  • Perform co-localization studies using confocal microscopy with appropriate controls

• Functional validation:

  • Verify whether antibody binding affects SOBER1's ability to suppress effector-triggered immunity

  • Test if antibodies interfere with SOBER1's deacetylase activity toward effector proteins

  • Determine if antibodies affect the interaction between SOBER1 and substrates like ACIP1, which is acetylated by AvrBsT

• Controls and validation:

  • Use bacterial effector mutants with altered binding capacity

  • Include non-interacting effectors as negative controls

  • Employ multiple detection methods to corroborate findings

Research has shown that SOBER1 can suppress immunity triggered by multiple bacterial acetyltransferases but not all tested acetyltransferase effectors, suggesting that SOBER1 might target components shared between several ETI pathways .

What approaches can be used to study SOBER1's phospholipase activity using antibodies?

Studying SOBER1's phospholipase A2 activity with antibodies requires specialized methodological approaches:

• Activity assays combined with immunodetection:

  • Perform in-gel lipase activity assays followed by western blotting to confirm band identity

  • Develop ELISA-based activity assays using anti-SOBER1 antibodies for capture and substrate-specific detection

  • Use antibodies to immunoprecipitate SOBER1 followed by measurement of phosphatidylcholine (PC) hydrolysis activity

• Substrate tracking approaches:

  • Combine fluorescent phospholipid analogs with immunolocalization to track SOBER1-substrate interactions

  • Use antibodies against phosphatidic acid (PA) to monitor product accumulation in wildtype vs. SOBER1 overexpression lines

  • Correlate SOBER1 localization with sites of lipid metabolism during pathogen challenge

• Methodological workflow for activity correlation:

  • Fractionate plant extracts by chromatography

  • Measure phospholipase activity in each fraction

  • Quantify SOBER1 protein levels by quantitative immunoblotting

  • Correlate activity with protein abundance across fractions

• Inhibition studies:

  • Test whether antibodies themselves can inhibit SOBER1's phospholipase activity

  • Use chemical inhibition of PLA2 activity in leaves expressing SOBER1 and observe effects on HR response

  • Compare results between wildtype plants and those overexpressing SOBER1

Research has demonstrated that recombinant His6-SOBER1 hydrolyzed phosphatidylcholine (PC) but not phosphatidic acid (PA) or lysophosphatidylcholine (LysoPC) in vitro, indicating that the enzyme has phospholipase A2 activity .

How can researchers troubleshoot non-specific binding when using SOBER1 antibodies?

Troubleshooting non-specific binding with SOBER1 antibodies requires systematic methodology:

Diagnostic Approaches:

• Identify the source of non-specificity:

  • Compare western blots using extracts from wildtype and sober1 knockout plants

  • Perform peptide competition assays using the immunizing peptide

  • Test pre-immune serum (for polyclonal antibodies) to distinguish antibody-specific binding

• Characterize cross-reactive proteins:

  • Excise non-specific bands for mass spectrometry identification

  • Check for homologous hydrolases with similar molecular weights

  • Determine if cross-reactivity changes under different experimental conditions

Optimization Strategies:

• Buffer modifications:

  • Increase salt concentration (150-500 mM NaCl) to reduce ionic interactions

  • Adjust detergent type and concentration (try CHAPS instead of Triton X-100)

  • Add 1% BSA as recommended for blocking antibodies

  • Include 0.1% SDS for western blotting applications to increase stringency

• Antibody handling:

  • Pre-adsorb antibodies against acetone powder prepared from sober1 knockout plants

  • Affinity-purify antibodies using recombinant SOBER1

  • Titrate antibody concentration to find optimal signal-to-noise ratio

  • Reconstitute lyophilized antibodies properly by first centrifuging the vial and using appropriate water

• Advanced solutions:

  • For immunohistochemistry: Extend blocking time and optimize antigen retrieval

  • For western blotting: Test different membrane types and blocking agents

  • Consider using isotype control antibodies for flow cytometry applications

Following these methodological adjustments should significantly reduce non-specific binding while maintaining sensitive detection of SOBER1.

What are the best practices for using SOBER1 antibodies in co-localization studies?

Co-localization studies with SOBER1 antibodies require rigorous methodology:

Sample Preparation:

• Fixation protocol:

  • Use 4% paraformaldehyde in PBS (pH 7.4) for 20-30 minutes

  • For membrane-associated studies, include 0.1-0.25% glutaraldehyde to better preserve lipid structures where SOBER1 may localize

  • Perform mild permeabilization with 0.1% Triton X-100 for 10-15 minutes

• Antigen retrieval:

  • Test citrate buffer (pH 6.0) heat-mediated retrieval if initial staining is weak

  • Optimize retrieval time based on tissue type and fixation conditions

Immunostaining Protocol:

• Blocking optimization:

  • Block with 3-5% BSA as recommended for antibody applications

  • Include 0.05% NaN₃ as used in antibody formulations to prevent contamination

  • Extend blocking to minimize background signal

• Antibody application:

  • Use carefully titrated primary antibody dilutions (typically 1:100 to 1:500)

  • For co-localization, select compatible primary antibodies from different species

  • Ensure antibodies recognize native conformation if detecting non-denatured proteins

Co-localization Partners:

• Functional partners to consider:

  • Bacterial effectors (AvrBsT, HopZ5) with epitope tags

  • Components of phospholipid signaling pathways, especially those involving PA

  • Microtubule-associated protein ACIP1, which is a substrate of AvrBsT and potentially deacetylated by SOBER1

• Imaging and Analysis:

  • Use confocal microscopy with appropriate filter sets

  • Include single-labeled controls for each fluorophore

  • Calculate objective co-localization coefficients (Pearson's and Mander's)

  • Implement line scan analysis across cellular compartments

These best practices ensure robust co-localization data that accurately reflects SOBER1's subcellular distribution and interactions with effector proteins and immunity components.

How can researchers validate the specificity of SOBER1 antibodies across different plant species?

Validating SOBER1 antibodies across plant species requires careful consideration of evolutionary conservation and methodological rigor:

• Epitope conservation analysis:

  • Perform multiple sequence alignment of SOBER1 orthologs across target species

  • Identify highly conserved regions as potential cross-reactive epitopes

  • Consider raising antibodies against species-specific regions for exclusive detection

  • Target regions with high conservation between Arabidopsis and Brassica species, where SOBER1 functions similarly

• Cross-species validation strategy:

  • Test antibodies on recombinant SOBER1 proteins from each species

  • Include lysates from wildtype and SOBER1-knockout/knockdown plants from each species

  • Perform epitope mapping to confirm antibody binding sites

  • Determine minimal epitope required for recognition across species

• Controlling for expression levels:

  • Use quantitative western blotting with recombinant protein standards

  • Normalize SOBER1 detection to conserved housekeeping proteins

  • Consider native protein concentration differences between species

• Functional correlation approaches:

  • Test whether antibody detection correlates with suppression of effector-triggered immunity across species

  • Compare antibody reactivity with SOBER1's ability to suppress phosphatidic acid accumulation in different species

  • Verify through complementary methods like mass spectrometry identification

• Methodological adjustments for cross-species use:

  • Optimize extraction buffers for each plant species' unique biochemistry

  • Adjust antibody concentrations based on empirical testing in each species

  • Consider species-specific blocking agents to reduce background

Research indicates that SOBER1's activity in suppressing hypersensitive response is significant not only in Arabidopsis but also appears to function similarly in the agriculturally important host Brassica napus , suggesting antibodies targeting conserved regions could work across these species.